Feasibility of Using Contrast Enhanced Voiding Urosonography (CeVUS) During Urodynamic Studies

Completed

Conditions studied: Neurogenic Bladder

In brief

The investigators will assess the feasibility of replacing fluoroscopy/iodinated contrast with ultrasound/sulfur hexafluoride lipid-type A microspheres during routine urodynamic studies.

Key facts

Study ID

NCT04170413

Run by

University of Virginia

People needed

25

Starts

2020-01-01

Expected to finish

2020-11-02

Last updated by the study team

2020-11-04

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 0-18
• Must have had prior urodynamic study at University of Virginia

You may not qualify if…

• Pregnant women
• Fetuses
• Neonates
• Prisoners
• Subjects with preexisting cardiac conditions (such as heart failure and ventricular arrhythmias)
• Subjects with a known hypersensitivity to Lumason

Where it is running

• University of Virginia — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.